Michael Blank a, ⁎
, Richard C. Wilson a, b, c, d, Yu Wan a, b, e, Joanna Peters a, Frances Davies a, b, Lidia Tyszczuk a, Bruno Pichon e, Alaa Riezk b, c, Alicia Demirjian b, e, f, g, h, Colin Stewart Brown e, Mark Gilchrist a, b, c, Alison H. Holmes b, c, d, Timothy Miles Rawson b, c, d
a Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 0HS. United Kingdom
b National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department for Infectious Disease, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN. United Kingdom
c Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom
d David Price Evans Infectious Diseases & Global Health Group, The University of Liverpool, Liverpool L7 8TX, United Kingdom
e Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, UK Health Security Agency (UKHSA), 61 Colindale Avenue London NW9 5EQ, United Kingdom
f Department of Paediatric Infectious Disease & Immunology, Evelina London Children’s Hospital, London, UK
g Faculty of Life Sciences & Medicine, Kings College London, London, UK
h Faculty of Medicine, Imperial College London, London, UK